Materialise: Medical And Software-Led Rebound

Group 1 - Materialise NV's (MTLS) stock has rebounded following its Q4 earnings report, indicating a potential return to consistent growth and improving margins [1] - The Medical segment of Materialise is performing well, contributing positively to the company's outlook [1] - Narweena, an asset manager led by Richard Durant, focuses on identifying market dislocations due to misunderstandings of long-term business prospects, aiming for excess risk-adjusted returns through secular growth opportunities [1] Group 2 - Narweena's investment strategy emphasizes company and industry fundamentals to uncover unique insights, with a high risk appetite and a long-term investment horizon [1] - The firm targets smaller cap stocks and markets where competitive advantages are not immediately apparent, driven by the belief that an aging population and low growth will create new investment opportunities [1] - The economic landscape is shifting towards asset-light businesses, leading to a decline in infrastructure investment needs, which is resulting in a large pool of capital chasing limited investment opportunities, thus driving up asset prices and compressing risk premia [1]